E-LIB Suche - Ergebnisse für: Tolcher, A.

1

Phase 1 Study of the Tissue Factor–Targeting Antibody-Drug ..:

Ulahannan, S. ; Johnson, M. ; Weiss, M....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e31-e32 , 2024

Link: https://doi.org/10.1016/..

2

Preliminary results from HERKULES-1: a phase 1b/2, open-lab..:

Wang, J. ; Johnson, M. ; Barve, M....
European Journal of Cancer. 174 (2022) - p. S80-S81 , 2022

Link: https://doi.org/10.1016/..

3

Archival vs fresh tumor samples for assessing the gene expr..:

Lu, M. ; Shaw, P. ; Richardson, D....
European Journal of Cancer. 174 (2022) - p. S88-S89 , 2022

Link: https://doi.org/10.1016/..

4

CBX-12-101: A first-in-human study of CBX-12, an alphalex p..:

Meric-Bernstam, F. ; Eder, J.P. ; Vandross, A....
European Journal of Cancer. 174 (2022) - p. S7-S8 , 2022

Link: https://doi.org/10.1016/..

5

A Phase 1 study of the anti-tissue factor antibody-drug con..:

Ulahannan, S. ; Johnson, M.L. ; Park, H....
European Journal of Cancer. 174 (2022) - p. S92-S93 , 2022

Link: https://doi.org/10.1016/..

6

MA13.07 TROPION-Lung02: Initial Results for Datopotamab Der..:

Levy, B. ; Paz-Ares, L. ; Rixe, O....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S91 , 2022

Link: https://doi.org/10.1016/..

7

A phase 1 study of XMT-1536 in patients with solid tumors l..:

Richardson, D.L. ; Hamilton, E. ; Tolcher, A....
Gynecologic Oncology. 159 (2020) - p. 52 , 2020

Link: https://doi.org/10.1016/..

8

Establishment and characterization of a hormone dependent, ..:

Wick, M. ; Quinn, M. ; Mangold, A....
European Journal of Cancer. 69 (2016) - p. S113 , 2016

Link: https://doi.org/10.1016/..

9

Development and characterization of HER2+ T-DM1-resistant b..:

Wick, M. ; Moriarty, A. ; Quinn, M....
European Journal of Cancer. 69 (2016) - p. S59 , 2016

Link: https://doi.org/10.1016/..

10

338 Results from a phase 1 study of ARQ 092, a novel pan AK..:

Tolcher, A. ; Harb, W. ; Sachdev, J....
European Journal of Cancer. 51 (2015) - p. S66 , 2015

Link: https://doi.org/10.1016/..

11

361 Phase I, open-label, dose-escalating clinical and pharm..:

Hidalgo, M. ; Boni, V. ; Tolcher, A....
European Journal of Cancer. 51 (2015) - p. S74 , 2015

Link: https://doi.org/10.1016/..

12

362 Phase 1 study of the PSMA-targeted tubulysin small-mole..:

Ejadi, S. ; Vogelzang, N. ; Sartor, A...
European Journal of Cancer. 51 (2015) - p. S74-S75 , 2015

Link: https://doi.org/10.1016/..

13

389 A phase 1, dose-escalation, first-in-human study of ARQ..:

Papadopoulos, K. ; Tolcher, A. ; Kittaneh, M....
European Journal of Cancer. 50 (2014) - p. 125 , 2014

Link: https://doi.org/10.1016/..

14

342 A phase 1/2 study evaluating the safety, pharmacokineti..:

Tolcher, A. ; Goss, G. ; Gordon, M....
European Journal of Cancer. 50 (2014) - p. 111 , 2014

Link: https://doi.org/10.1016/..

15

320 First-in-human study with ARQ 092, a novel pan AKT-inhi..:

Saleh, M. ; Papadpoulos, K. ; Arabnia, A....
European Journal of Cancer. 50 (2014) - p. 104 , 2014

Link: https://doi.org/10.1016/..